Alphamab Oncology

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG0330A1013
HKD
6.95
-1.28 (-15.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlphamab Oncology VS Pharmaceuticals & Biotechnology
 
1D
-15.55%
-1.78%
1W
-17.65%
1.6%
1M
-5.31%
1.03%
YTD
98.57%
-4.17%
1Y
143.86%
0.26%
3Y
-18.04%
26.52%
5Y
-62.35%
-12.29%
10Y
-62.35%
13.4%
  • Stock Absolute Returns
  • Hang Seng Hong KongAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
40.4%
0%
40.4%
6 Months
85.33%
0%
85.33%
1 Year
143.86%
0%
143.86%
2 Years
-8.67%
0%
-8.67%
3 Years
-18.04%
0%
-18.04%
4 Years
-66.75%
0%
-66.75%
5 Years
-62.35%
0%
-62.35%

Alphamab Oncology for the last several years.

stock-summaryRisk Adjusted Returns v/s Hang Seng Hong Kong
Risk Adjusted Returns v/s stock-summary